Engineering the human gut commensal Bacteroides thetaiotaomicron with synthetic biology
- PMID: 35759819
- DOI: 10.1016/j.cbpa.2022.102178
Engineering the human gut commensal Bacteroides thetaiotaomicron with synthetic biology
Abstract
The role of the microbiome in health and disease is attracting the attention of researchers seeking to engineer microorganisms for diagnostic and therapeutic applications. Recent progress in synthetic biology may enable the dissection of host-microbiota interactions. Sophisticated genetic circuits that can sense, compute, memorize, and respond to signals have been developed for the stable commensal bacterium Bacteroides thetaiotaomicron, dominant in the human gut. In this review, we highlight recent advances in expanding the genetic toolkit for B. thetaiotaomicron and foresee several applications of this species for microbiome engineering. We provide our perspective on the challenges and future opportunities for the engineering of human gut-associated bacteria as living therapeutic agents.
Keywords: Bacteroides; Genetic circuits; Human gut commensal bacteria; Living medicines; Microbiota; Synthetic biology.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest T.K.L. is a co-founder of Senti Biosciences, Synlogic, Engine Biosciences, Tango Therapeutics, Corvium, BiomX, Eligo Biosciences, Bota.Bio, and Avendesora. T.K.L. also holds financial interests in nest.bio, Ampliphi, IndieBio, MedicusTek, Quark Biosciences, Personal Genomics, Thryve, Lexent Bio, MitoLab, Vulcan, Serotiny, and Avendesora. N.H. is an employee of JSR Corporation. Y.L. declares no competing interests.
Similar articles
-
Advances in synthetic biology toolboxes paving the way for mechanistic understanding and strain engineering of gut commensal Bacteroides spp. and Clostridium spp.Biotechnol Adv. 2023 Dec;69:108272. doi: 10.1016/j.biotechadv.2023.108272. Epub 2023 Oct 14. Biotechnol Adv. 2023. PMID: 37844770 Review.
-
Programming a Human Commensal Bacterium, Bacteroides thetaiotaomicron, to Sense and Respond to Stimuli in the Murine Gut Microbiota.Cell Syst. 2015 Jul 29;1(1):62-71. doi: 10.1016/j.cels.2015.06.001. Cell Syst. 2015. PMID: 26918244 Free PMC article.
-
Polysaccharides catabolism by the human gut bacterium -Bacteroides thetaiotaomicron: advances and perspectives.Crit Rev Food Sci Nutr. 2021;61(21):3569-3588. doi: 10.1080/10408398.2020.1803198. Epub 2020 Aug 11. Crit Rev Food Sci Nutr. 2021. PMID: 32779480
-
Xenosiderophore Utilization Promotes Bacteroides thetaiotaomicron Resilience during Colitis.Cell Host Microbe. 2020 Mar 11;27(3):376-388.e8. doi: 10.1016/j.chom.2020.01.010. Epub 2020 Feb 18. Cell Host Microbe. 2020. PMID: 32075741 Free PMC article.
-
Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications.Annu Rev Biomed Eng. 2018 Jun 4;20:277-300. doi: 10.1146/annurev-bioeng-062117-121019. Epub 2018 Mar 12. Annu Rev Biomed Eng. 2018. PMID: 29528686 Free PMC article. Review.
Cited by
-
Systems and synthetic biology-driven engineering of live bacterial therapeutics.Front Bioeng Biotechnol. 2023 Oct 19;11:1267378. doi: 10.3389/fbioe.2023.1267378. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37929193 Free PMC article. Review.
-
Engineering Microbial Consortia as Living Materials: Advances and Prospectives.ACS Synth Biol. 2024 Sep 20;13(9):2653-2666. doi: 10.1021/acssynbio.4c00313. Epub 2024 Aug 22. ACS Synth Biol. 2024. PMID: 39174016 Free PMC article. Review.
-
An engineered gut bacterium protects against dietary methylmercury exposure in pregnant mice.Cell Host Microbe. 2025 May 14;33(5):621-631.e7. doi: 10.1016/j.chom.2025.04.009. Epub 2025 May 1. Cell Host Microbe. 2025. PMID: 40315838
-
Effect of Bifidobacterium longum subsp. infantis YLGB-1496 on common diseases in pediatrics: a randomized, blinded, placebo-controlled trial.Front Nutr. 2025 Jul 1;12:1585504. doi: 10.3389/fnut.2025.1585504. eCollection 2025. Front Nutr. 2025. PMID: 40667442 Free PMC article.
-
Advancements in gene editing technologies for probiotic-enabled disease therapy.iScience. 2024 Aug 22;27(9):110791. doi: 10.1016/j.isci.2024.110791. eCollection 2024 Sep 20. iScience. 2024. PMID: 39286511 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources